-
公开(公告)号:US11147837B2
公开(公告)日:2021-10-19
申请号:US15256086
申请日:2016-09-02
申请人: Regents of the University of Minnesota , Intima Bioscience, Inc. , The United States of America, as represented by the Secretary, Department of Health and Human Services
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , R. Scott McIvor , David Largaespada , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: A61K35/17 , C07K14/715 , C12N15/113 , C07K14/47 , C07K14/725 , C12N5/0783 , C07K14/705 , C12N15/90 , C12N9/22 , C12N9/96 , C12N15/87
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US20200306309A1
公开(公告)日:2020-10-01
申请号:US16900363
申请日:2020-06-12
申请人: Regents of the University of Minnesota , Intima Bioscience, Inc. , The U.S.A. as Represented by the Secretary, Department of Health and Human Services
IPC分类号: A61K35/17 , C07K14/715 , C12N15/113 , C07K14/47 , C07K14/725 , C12N5/0783 , C07K14/705 , C12N15/90 , C12N9/22 , C12N9/96
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US20170067021A1
公开(公告)日:2017-03-09
申请号:US15256086
申请日:2016-09-02
IPC分类号: C12N5/0783 , C07K14/725 , A61K35/17 , C07K14/705
CPC分类号: A61K35/17 , C07K14/4718 , C07K14/70503 , C07K14/7051 , C07K14/70521 , C07K14/7158 , C12N5/0636 , C12N9/22 , C12N9/96 , C12N15/113 , C12N15/87 , C12N15/907 , C12N2310/20 , C12N2510/00 , C12N2800/80 , Y02A50/463
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
摘要翻译: 公开了用于治疗癌症的转基因组合物,例如非病毒载体和T细胞。 还公开了制备和使用转基因组合物治疗癌症的方法。
-
公开(公告)号:US11925664B2
公开(公告)日:2024-03-12
申请号:US16900368
申请日:2020-06-12
申请人: Regents of the University of Minnesota , Intima Bioscience, Inc. , The U.S.A., as Represented by the Secretary, Department of Health and Human Services
IPC分类号: A61K48/00 , A61K35/17 , C07K14/47 , C07K14/705 , C07K14/715 , C07K14/725 , C12N5/0783 , C12N9/22 , C12N9/96 , C12N15/07 , C12N15/113 , C12N15/90 , C12N15/87
CPC分类号: A61K35/17 , C07K14/4718 , C07K14/70503 , C07K14/7051 , C07K14/7158 , C12N5/0636 , C12N9/22 , C12N9/96 , C12N15/113 , C12N15/907 , C12N15/87 , C12N2310/20 , C12N2510/00
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US20220125843A1
公开(公告)日:2022-04-28
申请号:US17478615
申请日:2021-09-17
申请人: Regents of the University of Minnesota , Intima Bioscience, Inc. , The United States of America, as represented by the Secretary, Department of Health and Human Servic
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , R. Scott McIvor , David Largaespada , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: A61K35/17 , C07K14/47 , C12N9/22 , C12N9/96 , C07K14/725 , C12N15/90 , C07K14/715 , C12N15/113 , C07K14/705 , C12N5/0783 , C12N15/87
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US11583556B2
公开(公告)日:2023-02-21
申请号:US17003081
申请日:2020-08-26
申请人: Regents of the University of Minnesota , Intima Bioscience, Inc. , The U.S.A., as represented by the Secretary, Department of Health and Human Services
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , R. Scott McIvor , David Largaespada , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: C12N5/00 , A61K35/17 , C07K14/715 , C12N15/113 , C07K14/47 , C07K14/725 , C12N5/0783 , C07K14/705 , C12N15/90 , C12N9/22 , C12N9/96 , C12N15/87
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
-
-
-
-